16856215

Source:http://linkedlifedata.com/resource/pubmed/id/16856215

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0078569, umls-concept:C0168388, umls-concept:C0338908, umls-concept:C1269683, umls-concept:C1707455, umls-concept:C1709323, umls-concept:C2348519
pubmed:issue	5
pubmed:dateCreated	2006-7-26
pubmed:abstractText	The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (MDD) and MDD with anxiety features to venlafaxine XR.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8702539
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanols, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Morpholines, http://linkedlifedata.com/resource/pubmed/chemical/reboxetine, http://linkedlifedata.com/resource/pubmed/chemical/venlafaxine
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0885-6222
pubmed:author	pubmed-author:AkgozSemraS, pubmed-author:AkkayaCengizC, pubmed-author:EkerSalih SayginSS, pubmed-author:KirliSelcukS, pubmed-author:SivriogluEnver YusufEY
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	337-45
pubmed:dateRevised	2008-3-6
pubmed:meshHeading	pubmed-meshheading:16856215-Adolescent, pubmed-meshheading:16856215-Adult, pubmed-meshheading:16856215-Aged, pubmed-meshheading:16856215-Antidepressive Agents, pubmed-meshheading:16856215-Anxiety, pubmed-meshheading:16856215-Cyclohexanols, pubmed-meshheading:16856215-Delayed-Action Preparations, pubmed-meshheading:16856215-Depressive Disorder, Major, pubmed-meshheading:16856215-Drug Administration Schedule, pubmed-meshheading:16856215-Drug Evaluation, pubmed-meshheading:16856215-Female, pubmed-meshheading:16856215-Follow-Up Studies, pubmed-meshheading:16856215-Humans, pubmed-meshheading:16856215-Male, pubmed-meshheading:16856215-Middle Aged, pubmed-meshheading:16856215-Morpholines, pubmed-meshheading:16856215-Psychiatric Status Rating Scales, pubmed-meshheading:16856215-Severity of Illness Index, pubmed-meshheading:16856215-Time Factors, pubmed-meshheading:16856215-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
pubmed:affiliation	Psychiatry Department, Uludag University, Medical Faculty, Bursa, Turkey.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial